In our data, serum PAI-1 concentrations increased with the rise of resistin levels unexplained by CV risk in both groups—CKD (p = 0.038) and participants with eGFR ≥ 60 mL/min/1.73 m2 (p < 0.001). Here, SERPINE1 is linked to chronic kidney disease.